Sponsored Links
With the announced U.S. release of Vitaros on February 28, 2011, Apricus Biosciences, Inc. may have just revolutionized the multi-billion dollar market for erectile dysfunction remedies. Hailed by some as a superior alternative to industry mainstays Levitra, Viagra, and Cialis, Vitaros makes its American debut after a promising 2010 unveiling in Europe saw it grab a significant share of the $1.2 billion E.U. market for ED treatments.
Read More...
